{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:12:29Z","timestamp":1776705149074,"version":"3.51.2"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"am","delay-in-days":391,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaesthesia Critical Care &amp; Pain Medicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.accpm.2020.03.007","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T11:44:12Z","timestamp":1583581452000},"page":"179-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation"],"prefix":"10.1016","volume":"39","author":[{"given":"Jean-Jacques","family":"Rouby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Monsel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Mimoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Fran\u00e7ois","family":"Laterre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Pugin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.accpm.2020.03.007_bib0140","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/ALN.0b013e3182755d7a","article-title":"Aerosolized antibiotics for ventilator-associated pneumonia: lessons from experimental studies","volume":"117","author":"Rouby","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.accpm.2020.03.007_bib0145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/cid\/ciw504","article-title":"Executive summary: management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.accpm.2020.03.007_bib0150","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cmi.2017.04.011","article-title":"Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases","volume":"23","author":"Rello","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.accpm.2020.03.007_bib0155","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.cmi.2017.03.018","article-title":"Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients","volume":"23","author":"Rello","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.accpm.2020.03.007_bib0160","first-page":"83","article-title":"Hospital-acquired pneumonia in ICU","volume":"37","author":"Leone","year":"2018","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.accpm.2020.03.007_bib0165","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.cmi.2019.04.018","article-title":"Why don\u2019t we have more inhaled antibiotics to treat ventilator-associated pneumonia?","volume":"25","author":"Sweeney","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.accpm.2020.03.007_bib0170","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.chest.2016.11.026","article-title":"A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of gram-negative ventilator-associated pneumonia: IASIS trial","volume":"151","author":"Kollef","year":"2017","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.accpm.2020.03.007_bib0175","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1473-3099(19)30574-2","article-title":"Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial","volume":"20","author":"Niederman","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.accpm.2020.03.007_bib0180","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00134-019-05914-5","article-title":"Effect of adjunctive tobramycin inhalation versus placebo on early clinical response in the treatment of ventilator-associated pneumonia: the VAPORISE randomized-controlled trial","volume":"46","author":"Stokker","year":"2020","journal-title":"Int Care Med"},{"issue":"1","key":"10.1016\/j.accpm.2020.03.007_bib0185","article-title":"Beta lactam antibiotic mono-therapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis","author":"Paul","year":"2014","journal-title":"Coch Datab Syst Rev"},{"issue":"10","key":"10.1016\/j.accpm.2020.03.007_bib0190","article-title":"Antibiotics for ventilator-associated pneumonia","author":"Arthur","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.accpm.2020.03.007_bib0195","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.accpm.2020.03.007_bib0200","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/ALN.0000000000002752","article-title":"Lung pharmacokinetics of tobramycin by intravenous and nebulized dosing in a mechanically ventilated healthy ovine model","volume":"131","author":"Dhanani","year":"2019","journal-title":"Anesthesiology"},{"key":"10.1016\/j.accpm.2020.03.007_bib0205","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ccc.2010.12.001","article-title":"Antimicrobial therapy of sepsis and septic shock--when are two drugs better than one?","volume":"27","author":"Abad","year":"2011","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.accpm.2020.03.007_bib0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ja.2011.101","article-title":"Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients","volume":"65","author":"Bozkurt-G\u00fczel","year":"2012","journal-title":"J Antibiot"},{"key":"10.1016\/j.accpm.2020.03.007_bib0215","article-title":"Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin","author":"Rouby","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2020.03.007_bib0220","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13054-017-1844-5","article-title":"Aerosol delivery during invasive mechanical ventilation: a systematic review","volume":"21","author":"Dugernier","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2020.03.007_bib0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/jamp.2016.1347","article-title":"Effect of heat moisture exchanger on aerosol drug delivery and airway resistance in simulated ventilator-dependent adults using jet and mesh nebulizers","volume":"31","author":"Ari","year":"2018","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.accpm.2020.03.007_bib0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pupt.2017.10.009","article-title":"Size distribution of salbutamol\/ipratropium aerosols produced by different nebulizers in the absence and presence of heat and humidification","volume":"48","author":"Yang","year":"2018","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.accpm.2020.03.007_bib0235","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1164\/rccm.200210-1167OC","article-title":"Aerosol delivery and modern mechanical ventilation: in vitro\/in vivo evaluation","volume":"168","author":"Miller","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.accpm.2020.03.007_bib0240","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.hrtlng.2017.08.004","article-title":"Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients","volume":"46","author":"Moustafa","year":"2017","journal-title":"Heart Lung"},{"key":"10.1016\/j.accpm.2020.03.007_bib0245","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4187\/respcare.05803","article-title":"How should aerosols be delivered during invasive mechanical ventilation?","volume":"62","author":"Dhand","year":"2017","journal-title":"Respir Care"},{"key":"10.1016\/j.accpm.2020.03.007_bib0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13613-016-0169-x","article-title":"Aerosol delivery with two ventilation modes during mechanical ventilation: a randomized study","volume":"6","author":"Dugernier","year":"2016","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.accpm.2020.03.007_bib0255","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/jamp.2014.1131","article-title":"Influence of inspiratory flow pattern and nebulizer position on aerosol delivery with a vibrating-mesh nebulizer during invasive mechanical ventilation: an in vitro analysis","volume":"28","author":"Dugernier","year":"2015","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.accpm.2020.03.007_bib0260","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1164\/ajrccm.154.2.8756810","article-title":"Aerosol delivery from a metered-dose inhaler during mechanical ventilation","volume":"154","author":"Fink","year":"1996","journal-title":"An in vitro model. Am J Respir Crit Care Med"},{"key":"10.1016\/j.accpm.2020.03.007_bib0265","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1186\/cc8206","article-title":"Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia","volume":"13","author":"Luyt","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2020.03.007_bib0270","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/ALN.0000000000002824","article-title":"Nebulized antibiotics: epithelial lining fluid concentrations overestimate lung tissue concentrations","volume":"131","author":"Rouby","year":"2019","journal-title":"Anesthesiology"}],"container-title":["Anaesthesia Critical Care &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556820300394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556820300394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:46:07Z","timestamp":1762479967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352556820300394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2352556820300394"],"URL":"https:\/\/doi.org\/10.1016\/j.accpm.2020.03.007","relation":{},"ISSN":["2352-5568"],"issn-type":[{"value":"2352-5568","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation","name":"articletitle","label":"Article Title"},{"value":"Anaesthesia Critical Care & Pain Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.accpm.2020.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise d'anesth\u00e9sie et de r\u00e9animation (Sfar). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}